Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-06-10

Clinical Trial Results: RegoNivo vs Standard of Care Chemotherapy in AGOC [Phase 3]

View source ↗

Summary

Phase 3 trial comparing RegoNivo to standard of care chemotherapy in gastro-oesophageal cancer has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RegoNivo

Snippet

Sponsor: Australasian Gastro-Intestinal Trials Group | Conditions: Gastro-Oesophageal Cancer | Phase 3 | Status: COMPLETED | Results posted: 2026-06-10